Two Clinical Trials Assessing Treatments for Eosinophilic Esophagitis

N Engl J Med. 2024 Sep 19;391(11):1066. doi: 10.1056/NEJMc2409416.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antibodies, Monoclonal, Humanized* / administration & dosage
  • Antibodies, Monoclonal, Humanized* / adverse effects
  • Eosinophilic Esophagitis* / diagnosis
  • Eosinophilic Esophagitis* / drug therapy
  • Eosinophilic Esophagitis* / immunology
  • Eosinophilic Esophagitis* / pathology
  • Humans
  • Immune Tolerance / drug effects
  • Randomized Controlled Trials as Topic
  • Treatment Outcome

Substances

  • Antibodies, Monoclonal, Humanized
  • mepolizumab